GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Improve Medical Instruments Co Ltd (SZSE:300030) » Definitions » ROIC %

Improve Medical Instruments Co (SZSE:300030) ROIC % : 2.34% (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Improve Medical Instruments Co ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Improve Medical Instruments Co's annualized return on invested capital (ROIC %) for the quarter that ended in Sep. 2024 was 2.34%.

As of today (2025-03-04), Improve Medical Instruments Co's WACC % is 3.24%. Improve Medical Instruments Co's ROIC % is 0.67% (calculated using TTM income statement data). Improve Medical Instruments Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Improve Medical Instruments Co ROIC % Historical Data

The historical data trend for Improve Medical Instruments Co's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Improve Medical Instruments Co ROIC % Chart

Improve Medical Instruments Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.75 13.13 3.65 -1.03 -0.41

Improve Medical Instruments Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 -6.23 4.97 2.34 2.34

Competitive Comparison of Improve Medical Instruments Co's ROIC %

For the Medical Instruments & Supplies subindustry, Improve Medical Instruments Co's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Improve Medical Instruments Co's ROIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Improve Medical Instruments Co's ROIC % distribution charts can be found below:

* The bar in red indicates where Improve Medical Instruments Co's ROIC % falls into.



Improve Medical Instruments Co ROIC % Calculation

Improve Medical Instruments Co's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=-3.679 * ( 1 - -39.84% )/( (1312.325 + 1226.033)/ 2 )
=-5.1447136/1269.179
=-0.41 %

where

Invested Capital(A: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1558.18 - 166.078 - ( 224.046 - max(0, 638.465 - 718.242+224.046))
=1312.325

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1425.956 - 138.859 - ( 237.714 - max(0, 603.369 - 664.433+237.714))
=1226.033

Improve Medical Instruments Co's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Sep. 2024 is calculated as:

ROIC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=25.192 * ( 1 - -5.04% )/( (1125.115 + 1132.477)/ 2 )
=26.4616768/1128.796
=2.34 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1325.078 - 115.963 - ( 188.161 - max(0, 494.917 - 578.917+188.161))
=1125.115

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1330.659 - 113.794 - ( 249.829 - max(0, 535.196 - 619.584+249.829))
=1132.477

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Improve Medical Instruments Co  (SZSE:300030) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Improve Medical Instruments Co's WACC % is 3.24%. Improve Medical Instruments Co's ROIC % is 0.67% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Improve Medical Instruments Co ROIC % Related Terms

Thank you for viewing the detailed overview of Improve Medical Instruments Co's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Improve Medical Instruments Co Business Description

Traded in Other Exchanges
N/A
Address
No.102 Kaiyuan Avenue, Science City, Luogang District, Guangdong, Guangzhou, CHN, 510530
Improve Medical Instruments Co Ltd, formerly Guangzhou Improve Medical Instruments Co Ltd is engaged in providing medical device product platform and medical services. The business of the company includes clinical laboratory specimen solutions, clinical laboratory diagnosis, imaging diagnosis, health management, and hospital digital overall solutions.
Executives
Deng Guan Hua Directors, executives
Tian Ke Executives
Li Zhuo Director
Xie Shi Song Independent director
Qian Chuan Rong Executives
Lian Qing Ming Director
Shen Yi Shan Director
Shen Zi Yu Director
Zheng Gui Hua Secretary Dong
Xu Li Xin Executives
Yan Hong Yu Directors, executives
Yu Xiu An Supervisors
Yang Li Supervisors
Zhao Ji Qing Director
Ma Hai Bo Executives

Improve Medical Instruments Co Headlines

No Headlines